Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
Authors
Keywords
-
Journal
SCIENCE
Volume 350, Issue 6266, Pages 1391-1396
Publisher
American Association for the Advancement of Science (AAAS)
Online
2015-11-06
DOI
10.1126/science.aaa5004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Untargeted metabolite profiling of murine embryos to reveal metabolic perturbations associated with neural tube closure defects
- (2014) Alex Hansler et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Correlation Between PET/CT Parameters and KRAS Expression in Colorectal Cancer
- (2014) Shang-Wen Chen et al. CLINICAL NUCLEAR MEDICINE
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
- (2013) J. L. Welsh et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
- (2013) Christopher M. Stephenson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Hypoxia-inducible Factor Renders Cancer Cells More Sensitive to Vitamin C-induced Toxicity
- (2013) Weihua Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells
- (2013) Saleha B. Vuyyuri et al. PLoS One
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer
- (2012) K. Kawada et al. CLINICAL CANCER RESEARCH
- Enhanced antitumor activity of vitamin C via p53 in Cancer cells
- (2012) Jinsun Kim et al. FREE RADICAL BIOLOGY AND MEDICINE
- A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue
- (2012) Min Yuan et al. Nature Protocols
- Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
- (2012) Daniel A. Monti et al. PLoS One
- Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
- (2012) A. G. Schepers et al. SCIENCE
- NAD+ Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death
- (2010) C. C. Alano et al. JOURNAL OF NEUROSCIENCE
- Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions
- (2009) Na Rae Hwang et al. BIOCHEMICAL JOURNAL
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
- (2008) L. J. Hoffer et al. ANNALS OF ONCOLOGY
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Crypt stem cells as the cells-of-origin of intestinal cancer
- (2008) Nick Barker et al. NATURE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started